Proteomics International is pleased to announce TGA regulatory approval granted for PromarkerD software as an in vitro diagnostic (IVD) for export use, and the granting of a key PromarkerD patent in Indonesia.
The broadening of Proteomics International’s IP portfolio reflects the ambitions to execute licensing transactions globally, the granting of the Indonesian patent secures another potentially lucrative jurisdiction.
